PFG Private Wealth Management’s Gilead Sciences GILD Stock Holding History

PFG Private Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-26	Closed	-$2.91K	–	128
2025 Q1	$2.91K	Sell	26 -8	-24%	-$825	﹤0.01%	209
2024 Q4	$3.14K	Hold	34	–	–	﹤0.01%	181
2024 Q3	$2.85K	Hold	34	–	–	﹤0.01%	189
2024 Q2	$2.33K	Hold	34	–	–	﹤0.01%	198
2024 Q1	$2.49K	Hold	34	–	–	﹤0.01%	187
2023 Q4	$2.75K	Sell	34 -409	-92%	-$31.8K	﹤0.01%	185
2023 Q3	$33.2K	Sell	443 -745	-63%	-$57.3K	0.02%	128
2023 Q2	$91.6K	Buy	1,188 +120	+11%	+$9.57K	0.05%	116
2023 Q1	$88.6K	Buy	+1,068	New	+$88.5K	0.06%	117

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

PFG Private Wealth Management's GILD Position: Q2 2025 in Review

PFG Private Wealth Management sold out of Gilead Sciences (GILD) in Q2 2025, closing a stake of 26 shares — an estimated $2.91K sold.

PFG Private Wealth Management first reported a position in GILD in Q1 2023 and held it in 9 quarters. The position peaked at $91.6K in Q2 2023. 2,023 funds tracked by Wall St. Rank hold GILD as of Q2 2025.

PFG Private Wealth Management reported no remaining Gilead Sciences position as of Q2 2025 after selling out during the quarter.
PFG Private Wealth Management sold 26 Gilead Sciences shares in Q2 2025, an estimated $2.91K.
PFG Private Wealth Management first reported a position in Gilead Sciences in Q1 2023 and held it in 9 quarters.
PFG Private Wealth Management's Gilead Sciences position peaked at $91.6K in Q2 2023.
2,023 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2025.

Based on PFG Private Wealth Management's 13F filing for Q2 2025, filed 11 Aug 2025.